These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12235103)

  • 21. Interleukin-6 plays a protective role in development of cisplatin-induced acute renal failure through upregulation of anti-oxidative stress factors.
    Mitazaki S; Honma S; Suto M; Kato N; Hiraiwa K; Yoshida M; Abe S
    Life Sci; 2011 Jun; 88(25-26):1142-8. PubMed ID: 21570986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.
    Kim JH; Park DJ; Yun JC; Jung MH; Yeo HD; Kim HJ; Kim DW; Yang JI; Lee GW; Jeong SH; Roh GS; Chang SH
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1141-50. PubMed ID: 22205231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RETRACTED: Protective effects of ghrelin on cisplatin-induced nephrotoxicity in mice.
    Nojiri T; Hosoda H; Kimura T; Tokudome T; Miura K; Takabatake H; Miyazato M; Okumura M; Kangawa K
    Peptides; 2016 Aug; 82():85-91. PubMed ID: 27298204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tannic acid mitigates cisplatin-induced nephrotoxicity in mice.
    Ahmad ST; Sultana S
    Hum Exp Toxicol; 2012 Feb; 31(2):145-56. PubMed ID: 21724663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of propofol on endotoxemia-induced acute kidney injury in rats.
    Cui WY; Tian AY; Bai T
    Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):747-54. PubMed ID: 21824173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity.
    Liu L; Yang C; Herzog C; Seth R; Kaushal GP
    Biochem Pharmacol; 2010 Jan; 79(2):137-46. PubMed ID: 19699182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.
    Perazella MA; Moeckel GW
    Semin Nephrol; 2010 Nov; 30(6):570-81. PubMed ID: 21146122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydrotestosterone as mediator for cisplatin induced nephrotoxicity: New insight down the road.
    El-Arabey AA
    Toxicology; 2017 Jul; 387():108. PubMed ID: 28587785
    [No Abstract]   [Full Text] [Related]  

  • 29. Cisplatin-induced renal toxicity magn…ified: role of magnesium deficiency in AKI onset.
    Romani AM
    Am J Physiol Renal Physiol; 2015 Dec; 309(12):F1005-6. PubMed ID: 26511648
    [No Abstract]   [Full Text] [Related]  

  • 30. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
    Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
    Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of recombinant human erythropoietin against cisplatin-induced oxidative stress and nephrotoxicity in rat kidney.
    Rjiba-Touati K; Boussema IA; Belarbia A; Achour A; Bacha H
    Int J Toxicol; 2011 Oct; 30(5):510-7. PubMed ID: 22013135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats.
    Beytur A; Köse E; Sarihan ME; Sapmaz HI; Dogan Z; Cetin A; Vardi N; Turkoz Y; Ekinci N
    Ren Fail; 2012; 34(3):343-9. PubMed ID: 22260262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug induced AKI].
    Tabei K
    Nihon Jinzo Gakkai Shi; 2010; 52(5):534-40. PubMed ID: 20715582
    [No Abstract]   [Full Text] [Related]  

  • 34. Minimization of cisplatin nephrotoxicity in high-risk patients.
    Donadio C; Lucchesi A; Gadducci A
    Nephron; 1996; 73(2):325-6. PubMed ID: 8773370
    [No Abstract]   [Full Text] [Related]  

  • 35. Amelioration of cisplatin-induced rat renal lesions by a cyclooxygenase (COX)-2 selective inhibitor.
    Yamamato E; Izawa T; Sawamoto O; Juniantito V; Kuwamura M; Yamate J
    Exp Toxicol Pathol; 2012 Sep; 64(6):625-31. PubMed ID: 21256724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KDIGO (Kidney Disease: Improving Global Outcomes) criteria could be a useful outcome predictor of cisplatin-induced acute kidney injury.
    Mizuno T; Sato W; Ishikawa K; Shinjo H; Miyagawa Y; Noda Y; Imai E; Yamada K
    Oncology; 2012; 82(6):354-9. PubMed ID: 22722365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
    Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.
    Li S; Gokden N; Okusa MD; Bhatt R; Portilla D
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F469-80. PubMed ID: 15814532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
    Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acquired resistance to acute renal failure in cisplatin-induced renal failure of rats].
    Ming CJ; Ohishi K; Yonemura K; Hishida A
    Nihon Jinzo Gakkai Shi; 1997 Oct; 39(7):728-33. PubMed ID: 9396240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.